Samrat Pharmachem Ltd vs Starsource Multitrade Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 10, 2026

Key Highlights

The Latest Trading Price of Samrat Pharmachem Ltd is ₹ 214.95 as of 08 May 15:30 . The P/E Ratio of Samrat Pharmachem Ltd changed from 7.9 on March 2021 to 13.6 on March 2025 . This represents a CAGR of 11.48% over 5 yearsThe P/E Ratio of Starsource Multitrade Ltd changed from 10.7 on March 2021 to 54.7 on March 2025 . This represents a CAGR of 38.59% over 5 years The Market Cap of Samrat Pharmachem Ltd changed from ₹ 42.02 crore on March 2021 to ₹ 96.63 crore on March 2025 . This represents a CAGR of 18.12% over 5 yearsThe Market Cap of Starsource Multitrade Ltd changed from ₹ 2.68 crore on March 2021 to ₹ 18.69 crore on March 2025 . This represents a CAGR of 47.47% over 5 years The revenue of Samrat Pharmachem Ltd for the Dec '25 is ₹ 63.83 crore as compare to the Sep '25 revenue of ₹ 78.92 crore. This represent the decline of -19.12% The revenue of Starsource Multitrade Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0.53 crore. This represent the decline of -100% The ebitda of Samrat Pharmachem Ltd for the Dec '25 is ₹ -0.26 crore as compare to the Sep '25 ebitda of ₹ -0.31 crore. This represent the decline of -16.13% The ebitda of Starsource Multitrade Ltd for the Dec '25 is ₹ -0.09 crore as compare to the Sep '25 ebitda of ₹ 0.1 crore. This represent the decline of -190% The net profit of Samrat Pharmachem Ltd changed from ₹ 2.07 crore to ₹ -0.46 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Starsource Multitrade Ltd changed from ₹ 0.25 crore to ₹ -0.09 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Samrat Pharmachem Ltd changed from 1.8 % on March 2022 to 4.35 % on March 2025 . This represents a CAGR of 24.68% over 4 yearsThe Dividend Payout of Starsource Multitrade Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Samrat Pharmachem Ltd

Samrat Pharmachem Limited was incorporated on June 16, 1992 at Ankleshwar in Gujarat led by the Promoters, Mr. Lalit Mehta & Mr. Rajesh Mehta.
Since then, it envisioned to focus on lodine Derivatives as their core products.
The Company's principal activities are manufacturing and selling chemicals.
Company is a producer of pharmaceutical chemicals.
The intermediates produced are used in pharmaceutical and chemical industries.

About Starsource Multitrade Ltd

Starsource Multitrade Limited was initially established on August 17, 1942 under the name 'Chemo Pharma Laboratories Limited'.
Name of the Company is given a change in name with due approval from Registrar of Companies effected on August 12, 2025.
Initially, the Company had been making Pharmaceuticals and also diversified into bulk drugs. However due to increase in competition and flow of new drugs, the Company had to dispose the business and pay all its liabilities and dues.
Presently the Company has its own cash resource, with this the Company is proposing to diversify and to take over Sick Company which has excellent future potential.
The Company is in advance in the negotiation to some other company and soon rehab to acquire business in Power and Chemicals. The existing Main Objects of Clause III (A) be altered by replacing the same with the following new Clause to carry on the business of buying, selling, reselling, importing, exporting, transporting, storing, promoting, marketing or supplying, trading, dealing in any manner whatsoever in all type of goods and commodities on retail as well as on wholesale basis in India or elsewhere during the year 2025.

FAQs for the comparison of Samrat Pharmachem Ltd and Starsource Multitrade Ltd

Which company has a larger market capitalization, Samrat Pharmachem Ltd or Starsource Multitrade Ltd?

Market cap of Samrat Pharmachem Ltd is 66 Cr while Market cap of Starsource Multitrade Ltd is 17 Cr

What are the key factors driving the stock performance of Samrat Pharmachem Ltd and Starsource Multitrade Ltd?

The stock performance of Samrat Pharmachem Ltd and Starsource Multitrade Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Samrat Pharmachem Ltd and Starsource Multitrade Ltd?

As of May 10, 2026, the Samrat Pharmachem Ltd stock price is INR ₹214.95. On the other hand, Starsource Multitrade Ltd stock price is INR ₹115.0.

How do dividend payouts of Samrat Pharmachem Ltd and Starsource Multitrade Ltd compare?

To compare the dividend payouts of Samrat Pharmachem Ltd and Starsource Multitrade Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.